Kathleen Sullivan to Immunoglobulins, Intravenous
This is a "connection" page, showing publications Kathleen Sullivan has written about Immunoglobulins, Intravenous.
Connection Strength
0.744
-
Hagan JB, Wasserman RL, Baggish JS, Spycher MO, Berger M, Shashi V, Lohrmann E, Sullivan KE. Safety of L-proline as a stabilizer for immunoglobulin products. Expert Rev Clin Immunol. 2012 Feb; 8(2):169-78.
Score: 0.428
-
Costa-Carvalho BT, Sullivan KE, Fontes PM, Aim?-Nobre F, Gonzales IGS, Lima ES, Granato C, de Moraes-Pinto MI. Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment. J Clin Immunol. 2018 07; 38(5):628-634.
Score: 0.167
-
Notarangelo LD, Rawlings DJ, Sullivan KE. An exemplum of XLA. Clin Immunol. 2008 Feb; 126(2):137-9.
Score: 0.080
-
Cunningham-Rundles C, Routes JM, Hostoffer R, Sullivan KE. Uncommon conundrum in common variable immunodeficiency. Clin Immunol. 2005 Sep; 116(3):208-10.
Score: 0.069